spacer
home > ict > spring 2019 > achieving successful clinical evaluation reports
PUBLICATIONS
International Clinical Trials

Achieving Successful Clinical Evaluation Reports

Every medical device, whether it is an existing medical device on the market or a manufacturer launching a new product, needs to have an up-to-date clinical evaluation report (CER) as part of its technical file (irrespective of classification). Unless manufacturers have in-house CER specialists who can implement a comprehensive clinical evaluation strategy, the fundamental points of CER development and the steps which need to be taken to produce a successful and compliant CER are not always obvious.

The CER itself is a document that provides the notified body (NB) or other reviewers with adequate information to assess the appropriateness of the methodology, including data and overall conclusions. Not having the right expertise on hand to draft the CER means that various interpretations of the CER guidelines can occur. As the regulatory landscape evolves, the requirements CERs evolve too, making it more difficult for manufacturers to know if their approach to compliance is correct. The challenge to present properly supported CERs (particularly for devices that have faced safety issues in the past) is becoming tougher. However, failing to pass the CER could have drastic repercussions to some businesses, not only affecting where and how they can manufacture their products, but also impacting business reputation and, ultimately, the bottom line.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Efstathios Vassiliadis is a Solutions Delivery Manager at Maetrics, with experience in R&D, regulatory, technical writing, validation, and management in the medical device and pharmaceutical industry. He is an experienced leader directing large R&D, quality, regulatory, and management remediation and improvement programmes. Efstathios is a project lead and is currently supporting global remediation programmes for implementing new international regulatory requirements. Prior to Maetrics, Efstathios worked as director/head of department in both pharma and medical devices organisations, leading multi-disciplined projects from R&D to quality, production, technical, and management, covering almost the entire value chain.
spacer
Dr Efstathios Vassiliadis
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Organization Updates

Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following management updates to help drive the company’s future vision, strategy and growth.
More info >>

White Papers

Pharmaceuticals and Healthcare Products

Turkish Cargo

Pharmaceuticals are requiring safe and reliable transportation for being highly temperature sensitive products. Thosepharmaceuticals are; diagnostics, vaccines drugs, sera, plasma, protein clinical trials, biotechnological material, pills and all kind of medicines. Turkish Cargo transports all kind of pharmaceuticals, and has been carrying out its operations of transporting and storing drugs and temperature-sensitive medical supplies successfully and with the experience of 80 years; since 1936.
More info >>

 
Industry Events

SCOPE Europe – Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement